Compare · PPSI vs TMO
PPSI vs TMO
Side-by-side comparison of Pioneer Power Solutions Inc. (PPSI) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PPSI and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $254.47B, about 10638.4x PPSI ($23.9M).
- TMO has been more active in the news (9 items in the past 4 weeks vs 3 for PPSI).
- TMO has more recent analyst coverage (25 ratings vs 1 for PPSI).
- Company
- Pioneer Power Solutions Inc.
- Thermo Fisher Scientific Inc
- Price
- -
- -
- Market cap
- $23.9M
- $254.47B
- 1M return
- -
- +1.12%
- 1Y return
- -
- +19.28%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 3
- 9
- Recent ratings
- 1
- 25
Pioneer Power Solutions Inc.
Pioneer Power Solutions, Inc., together with its subsidiaries, manufactures, sells, and services specialty electrical transmission, distribution, and on-site power generation equipment in the United States, Canada, and internationally. The company operates in two segments, Transmission & Distribution Solutions and Critical Power Solutions. The Transmission & Distribution Solutions segment designs, develops, and manufactures low and medium voltage electric power distribution panel boards, low voltage switchgears, and switchboards. The Critical Power Solutions segment provides aftermarket field-services to ensure smooth and uninterrupted power to operations during times of emergency. It serves utility, industrial, commercial, and backup power markets. The company was incorporated in 2008 and is headquartered in Fort Lee, New Jersey. Pioneer Power Solutions, Inc. is a subsidiary of Provident Pioneer Partners, L.P.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest PPSI
- Pioneer Power Solutions Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders
- Pioneer Power Solutions Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Pioneer Power Announces a 41.7% Year-to-Date Increase in Backlog to $17.9 Million as of September 30, 2026, and Provides a Business Update
- SEC Form DEFA14A filed by Pioneer Power Solutions Inc.
- SEC Form DEF 14A filed by Pioneer Power Solutions Inc.
- SEC Form EFFECT filed by Pioneer Power Solutions Inc.
- SEC Form S-3 filed by Pioneer Power Solutions Inc.
- Pioneer to Participate in Upcoming Conferences in September
- Pioneer Power Solutions Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Pioneer Power Announces Financial Results for Second Quarter 2026 and Provides a Business Update
Latest TMO
- President & COO Pettiti Gianluca sold $2,898,969 worth of shares (4,133 units at $701.42) as part of a pre-agreed trading plan and exercised 3,733 shares at a strike of $309.63, decreasing direct ownership by 2% to 22,816 units (SEC Form 4)
- Thermo Fisher Scientific to Participate in UBS 2026 CEO Call Series on November 19, 2026
- Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases
- Thermo Fisher Scientific Announces Quarterly Dividend
- SEC Form SCHEDULE 13G filed by Thermo Fisher Scientific Inc
- Director Sperling Scott M gifted 3,490 shares, decreasing direct ownership by 5% to 65,989 units (SEC Form 4)
- Sr. VP and Chief HR Officer Britt Lisa P. sold $1,999,960 worth of shares (2,831 units at $706.45) (SEC Form 4)
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Leadership Update
- SEC Form 10-Q filed by Thermo Fisher Scientific Inc
- SEC Form 8-K filed by Thermo Fisher Scientific Inc